Raphael Pharmaceutical RAPH Balance Sheet (2020-2026)

OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Raphael Pharmaceutical Quarterly Balance Sheet

Periods 22 quarters
Latest Jun 2026

Raphael Pharmaceutical reported total assets of $0.01M and total liabilities of $1.89M for the quarter ended Jun 2026, down 92.5% year over year. This balance sheet covers 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
0.04M0.15M0.08M0.14M0.09M0.29M0.04M0.11M0.30M0.23M0.29M0.12M0.04M0.02M0.05M0.02M0.00M0.04M0.00M
Cash & Current Investments
0.04M0.15M0.08M0.14M0.09M0.29M0.04M0.11M0.30M0.23M0.29M0.12M0.04M0.02M0.05M0.02M0.00M0.04M0.00M
Receivables - NetNet Receivables
0.00M0.00M
Receivables - OtherOther Receivables
0.10M
Receivables
0.00M0.00M
Prepaid Assets
0.03M0.27M0.10M0.06M0.03M0.04M0.11M0.01M0.10M0.01M0.06M0.01M0.01M0.01M0.04M0.01M0.00M0.01M0.01M
Current Assets
0.06M0.42M0.18M0.20M0.12M0.33M0.15M0.12M0.40M0.24M0.35M0.13M0.05M0.03M0.09M0.03M0.01M0.05M0.01M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Intangibles
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Goodwill & Intangibles
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Long-Term Deferred Tax
5.75M3.20M5.74M6.96M8.83M
Non-Current Assets
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Assets
0.06M0.42M0.18M0.20M0.12M0.33M0.15M0.12M0.40M0.24M0.35M0.13M0.05M0.03M0.09M0.03M0.01M0.05M0.01M
Liabilities
Current Liabilities
Accounts Payables
0.01M0.27M0.07M0.07M0.12M0.16M
Notes Payables
0.02M0.00M0.01M0.00M0.04M0.04M0.04M0.04M0.03M0.13M0.23M0.41M0.56M0.76M0.95M1.31M
Payables
0.01M0.29M0.00M0.01M0.07M0.04M0.04M0.11M0.04M0.03M0.13M0.35M0.41M0.56M0.76M1.11M1.31M
Accumulated Expenses
0.17M0.27M0.08M0.06M0.18M0.22M0.15M0.14M0.44M0.09M0.42M0.39M0.54M0.50M0.38M0.47M0.47M0.51M0.54M
Other Accumulated Expenses
0.30M
Short term Debt
0.04M0.04M0.04M0.04M0.03M0.04M
Total Current Liabilities
0.19M0.29M0.08M0.08M0.18M0.23M0.16M0.18M0.48M0.13M0.46M0.42M0.67M0.77M0.83M1.08M1.27M1.49M1.89M
Non-Current Liabilities
Non-Current Debt
0.00M0.04M0.23M0.95M1.31M
Total Liabilities
-0.19M0.19M0.29M0.08M0.08M0.18M0.23M0.16M0.18M0.48M0.13M0.46M0.42M0.67M0.77M0.83M1.08M1.27M1.49M1.89M
Shareholder's Equity
Total Debt
0.02M0.00M0.01M0.01M0.04M0.04M0.08M0.04M0.03M0.13M0.50M0.45M0.60M0.80M1.93M2.66M
Common Equity
0.19M-0.12M0.13M0.10M0.12M-0.06M0.11M-0.01M-0.06M-0.07M0.11M-0.10M-0.29M-0.62M-0.74M-0.73M-1.05M-1.26M-1.43M-1.89M
Liabilities and Shareholders Equity
0.06M0.42M0.18M0.20M0.12M0.33M0.15M0.12M0.40M0.24M0.35M0.13M0.05M0.03M0.09M0.03M0.01M0.05M0.01M
Retained Earnings
-2.10M-2.67M-2.85M3.48M4.92M-6.03M-6.29M-6.71M-7.43M-7.37M-7.86M-8.11M-8.43M-8.89M-9.32M-9.64M-9.89M-10.17M-10.62M